Related Experiment Video
Updated: Aug 15, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Remission of HIV-associated myelopathy after highly active antiretroviral therapy
F J Fernández-Fernández1, J de la Fuente-Aguado, A Ocampo-Hermida
1Department of Internal Medicine, Complexo Hospitalario Universitario Xeral-Cíes, Vigo, Spain. fjfer@mundo-r.com
Abstract:
HIV-associated myelopathy is the leading cause of spinal cord disease in HIV-infected patients. Typically, it affects individuals with low CD4 T cell counts, presenting with slowly progressive spastic paraparesis associated with dorsal column sensory loss as well as urinary disturbances. Other aetiologies must be first ruled out before establishing the diagnosis. We report here the case of a 37-year-old woman with advanced HIV disease, who developed HIV-associated myelopathy. The patient showed a gradual improvement after beginning with highly active antiretroviral therapy and, finally, she achieved a complete functional recovery. In addition, neuroimaging and neurophysiological tests normalized.
Related Concept Videos
Retrovirus Life Cycles
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Cryptococcal Meningitis

